107 related articles for article (PubMed ID: 1672306)
1. Somatostatin analogue RC-160 inhibits the growth of transplanted colon cancer in rats.
Qin Y; Schally AV; Willems G
Int J Cancer; 1991 Mar; 47(5):765-70. PubMed ID: 1672306
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of somatostatin analogue RC-160 on the growth of hepatic metastases of colon cancer in rats: a study with magnetic resonance imaging.
Qin Y; Van Cauteren M; Osteaux M; Schally AV; Willems G
Cancer Res; 1992 Nov; 52(21):6025-30. PubMed ID: 1356623
[TBL] [Abstract][Full Text] [Related]
3. Treatment of liver metastases of human colon cancers in nude mice with somatostatin analogue RC-160.
Qin Y; Schally AV; Willems G
Int J Cancer; 1992 Nov; 52(5):791-6. PubMed ID: 1358828
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer.
Pinski J; Reile H; Halmos G; Groot K; Schally AV
Cancer Res; 1994 Jan; 54(1):169-74. PubMed ID: 7903203
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of antagonists of bombesin/gastrin releasing peptide (GRP) and somatostatin analog (RC-160) on growth of HT-29 human colon cancers in nude mice.
Radulovic S; Schally AV; Reile H; Halmos G; Szepeshazi K; Groot K; Milovanovic S; Miller G; Yano T
Acta Oncol; 1994; 33(6):693-701. PubMed ID: 7946450
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of growth of MKN45 human gastric-carcinoma xenografts in nude mice by treatment with bombesin/gastrin-releasing-peptide antagonist (RC-3095) and somatostatin analogue RC-160.
Pinski J; Halmos G; Yano T; Szepeshazi K; Qin Y; Ertl T; Schally AV
Int J Cancer; 1994 May; 57(4):574-80. PubMed ID: 7910153
[TBL] [Abstract][Full Text] [Related]
7. Effect of somatostatin analog RC-160 and bombesin/gastrin releasing peptide antagonist RC-3095 on growth of PC-3 human prostate-cancer xenografts in nude mice.
Pinski J; Schally AV; Halmos G; Szepeshazi K
Int J Cancer; 1993 Dec; 55(6):963-7. PubMed ID: 7902829
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.
Schally AV; Redding TW
Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7275-9. PubMed ID: 2890164
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and high dose of somatostatin analogue RC-160 on nitrosamine-induced pancreatic cancers in hamsters.
Szepeshazi K; Schally AV; Cai RZ; Radulovic S; Milovanovic S; Szoke B
Cancer Res; 1991 Nov; 51(21):5980-6. PubMed ID: 1682039
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin analogues and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of human glioblastomas in vitro and in vivo.
Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K
Cancer Res; 1994 Nov; 54(22):5895-901. PubMed ID: 7954420
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human endometrial cancer cell growth in vitro and in vivo by somatostatin analog RC-160.
Mishima M; Yano T; Jimbo H; Yano N; Morita Y; Yoshikawa H; Schally AV; Taketani Y
Am J Obstet Gynecol; 1999 Sep; 181(3):583-90. PubMed ID: 10486467
[TBL] [Abstract][Full Text] [Related]
12. Octreotide (SMS 201-995) inhibits the growth of colon peritoneal carcinomatosis in BDIX rats.
Ruszniewski P; Lehy T; Reyl-Desmars F; Le Roux S; Lewin MJ
Regul Pept; 1993 Feb; 43(3):141-7. PubMed ID: 8441819
[TBL] [Abstract][Full Text] [Related]
13. Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K; O'Byrne K; Cai RZ
Br J Cancer; 1994 Nov; 70(5):886-92. PubMed ID: 7947094
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of growth of HT-29 human colon cancer xenografts in nude mice by treatment with bombesin/gastrin releasing peptide antagonist (RC-3095).
Radulovic S; Miller G; Schally AV
Cancer Res; 1991 Nov; 51(21):6006-9. PubMed ID: 1682040
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the classical autoradiographic and the immunohistochemical methods with BrdU for measuring proliferation parameters in colon cancer.
Qin Y; Willems G
Anticancer Res; 1993; 13(3):731-5. PubMed ID: 8317905
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin analog RC-160 inhibits the growth of human osteosarcomas in nude mice.
Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K
Int J Cancer; 1996 Mar; 65(6):870-4. PubMed ID: 8631606
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of PC-3 human androgen-independent prostate cancer and its metastases by cytotoxic somatostatin analogue AN-238.
Plonowski A; Schally AV; Nagy A; Sun B; Szepeshazi K
Cancer Res; 1999 Apr; 59(8):1947-53. PubMed ID: 10213505
[TBL] [Abstract][Full Text] [Related]
18. Partial inhibition of the growth of transplanted dunning rat prostate tumors with the long-acting somatostatin analogue sandostatin (SMS 201-995).
Siegel RA; Tolcsvai L; Rudin M
Cancer Res; 1988 Aug; 48(16):4651-5. PubMed ID: 2899458
[TBL] [Abstract][Full Text] [Related]
19. Experimental radiotherapy of receptor-positive human prostate adenocarcinoma with 188Re-RC-160, a directly-radiolabeled somatostatin analogue.
Zamora PO; Gulhke S; Bender H; Diekmann D; Rhodes BA; Biersack HJ; Knapp FF
Int J Cancer; 1996 Jan; 65(2):214-20. PubMed ID: 8567120
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin analog RC-160 inhibits growth of CFPAC-1 human pancreatic cancer cells in vitro and intracellular production of cyclic adenosine monophosphate.
Qin Y; Ertl T; Groot K; Horvath J; Cai RZ; Schally AV
Int J Cancer; 1995 Mar; 60(5):694-700. PubMed ID: 7860145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
